SPARCL1 and metabolic dysfunction-associated steatohepatitis: A prior investigation revealed elevated plasma levels of Hevin in non‐alcoholic steatohepatitis (NASH), showing a correlation with the disease's severity in a human cohort (Liu et al. 2021).